VYNE Therapeutics Inc (VYNE) USD0.0001
Sell:$2.40Buy:$2.60
$0.10 (3.89%)
- This stock can be held in a
Stocks and Shares ISASell:$2.40
Buy:$2.60
Change:$0.10 (3.89%)
$0.10 (3.89%)Prices delayed by at least 15 minutes
Sell:$2.40
Buy:$2.60
Change:$0.10 (3.89%)
$0.10 (3.89%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 April 2024 | David DomzalskiPresident/CEO | Sell Tax related | 1,004 | $3.08 | $3,092.32 | 494,160 |
| 1 April 2024 | Mutya HarschChief Legal/Compliance Officer | Sell Tax related | 161 | $3.08 | $495.88 | 149,274 |
| 1 April 2024 | Iain StuartChief Level Officer | Sell Tax related | 157 | $3.08 | $483.56 | 133,741 |
| 1 April 2024 | Tyler ZerondaCFO | Sell Tax related | 94 | $3.08 | $289.52 | 131,743 |
| 2 January 2024 | David DomzalskiPresident/CEO | Sell Tax related | 1,004 | $2.28 | $2,289.12 | 495,164 |
| 2 January 2024 | Mutya HarschChief Legal/Compliance Officer | Sell Tax related | 161 | $2.28 | $367.08 | 149,435 |
| 2 January 2024 | Iain StuartChief Level Officer | Sell Tax related | 157 | $2.28 | $357.96 | 133,898 |
| 2 January 2024 | Tyler ZerondaCFO | Sell Tax related | 93 | $2.28 | $212.04 | 131,837 |
| 15 November 2023 | Patrick G LeporeIndependent Director | Buy Regular purchase transaction | 13,000 | $3.91 | $50,778.00 | 36,472 |
| 1 November 2023 | AI BIOTECHNOLOGY LLC5% Shareholder | Buy Regular purchase transaction | 1,116,585 | $2.25 | $2,506,733.33 | 1,116,585 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 November 2023 | AI BIOTECHNOLOGY LLC5% Shareholder | Buy Regular purchase transaction | 1,116,585 | $2.25 | $2,506,733.33 | 1,116,585 |
| 15 November 2023 | Patrick G LeporeIndependent Director | Buy Regular purchase transaction | 13,000 | $3.91 | $50,778.00 | 36,472 |
| 2 October 2023 | David DomzalskiPresident/CEO | Sell Tax related | 8,549 | $3.83 | $32,742.67 | 43,884 |
| 2 October 2023 | Iain StuartChief Level Officer | Sell Tax related | 1,184 | $3.83 | $4,534.72 | 9,055 |
| 2 October 2023 | Mutya HarschChief Legal/Compliance Officer | Sell Tax related | 1,154 | $3.83 | $4,419.82 | 24,596 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.